Specifically, the CD8+ T-cells target β-cell antigens, which are the 65-kilodalton isoforms of glutamic acid decarboxylase (GAD65), insulin, and pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP) that are presented in T1DM patients. This evidence concerns the gene CD8A and type 1 diabetes mellitus.